Each year, the United States has six million become infected with human papilloma virus (HPV). HPV is known to cause cervical cancer in women and associated with head and neck cancers in men.

Pap smears may soon become only a back-up screening for cervical cancer. New research shows one type of test may be best for ruling out the disease.

For some reason, doctors aren't following the recommended screening guidelines when it comes to cervical cancer. This screening doesn't necessarily have to be performed annually, though it often is. 

A radical hysterectomy used to be the only way to treat cervical cancer. The surgery left a woman with no chance of having children. Today, women have gentler choices that preserve fertility.

It used to be that your annual OB/ GYN check included a pap smear. For women over the age of 30, a study shows new recommendations may be in order.

While the origins of many cancers continue to overwhelm science, the cause of cervical cancer is well known - the human papillomavirus (HPV). And since the HPV vaccine program was introduced in Australia, research shows it's working.

Genetic testing is opening doors in the helping people understand the potential health issues they may face in the near and distant future.

While it's well known that invasive cervical cancer is the leading cause of cancer-related deaths in developing nations, many countries don't have the resources for adequate screening programs. Now there's a new model.

Having an abnormal pap smear in which "precancerous cervical lesions" show up is frightening for women. How these patients are followed may soon become less rigorous. Screening recommendations for women treated for precancerous cervical lesions have changed.

According to a recent study, young lesbian and bisexual women are not monitoring their sexual health as actively as heterosexual young women.